Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 2/20 | 0.50 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | FBP1 | P09467 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4936314 | 0.86 | AKR1C3 (0.44) | AKR1C3AKR1C1MEN1KMT2AHTT | |
| SCHEMBL4936319 | 0.86 | AKR1C3 (0.44) | AKR1C3AKR1C1MEN1KMT2AHTT | |
| SCHEMBL28178758 | 0.84 | MEN1 (0.44) | AKR1C3MEN1KMT2ANFKB1NFKB2 | |
| SCHEMBL4649014 | 0.83 | AKR1C3 (0.47) | AKR1C3AKR1C1MEN1KMT2AHTT | |
| SCHEMBL4649011 | 0.83 | AKR1C3 (0.47) | AKR1C3AKR1C1MEN1KMT2AHTT | |
| SCHEMBL5550086 | 0.83 | ALDH1A1 (0.38) | AKR1C3AKR1C1MEN1KMT2AHTT | |
| SCHEMBL7153123 | 0.83 | AKR1C3 (0.47) | AKR1C3AKR1C1MEN1KMT2AHTT | |
| SCHEMBL1546501 | 0.83 | AKR1C3 (0.44) | AKR1C3AKR1C1MEN1KMT2AHTT | |
| SCHEMBL5606671 | 0.81 | NR1H4 (0.56) | MEN1KMT2AALDH1A1ABCG2RECQL | |
| SCHEMBL5606669 | 0.81 | NR1H4 (0.56) | MEN1KMT2AALDH1A1ABCG2RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260126721-A1 | EXPANDABLE NEGATIVE PHOTORESIST WITH SUSPENSION MATERIAL AND METHOD FOR REDUCING HORN SHAPES IN SPACER OXIDE USING EXPANDABLE NEGATIVE PHOTORESIST | NANYA TECHNOLOGY CORP (TW) | 2026-05-07 | — | — | US | claimed |
| US-20260126722-A1 | EXPANDABLE NEGATIVE PHOTORESIST WITH SUSPENSION MATERIAL AND METHOD FOR REDUCING HORN SHAPES IN SPACER OXIDE USING EXPANDABLE NEGATIVE PHOTORESIST | NANYA TECHNOLOGY CORP (TW) | 2026-05-07 | — | — | US | claimed |
| US-20260126722-A1 | EXPANDABLE NEGATIVE PHOTORESIST WITH SUSPENSION MATERIAL AND METHOD FOR REDUCING HORN SHAPES IN SPACER OXIDE USING EXPANDABLE NEGATIVE PHOTORESIST | NANYA TECHNOLOGY CORP (TW) | 2026-05-07 | — | — | US | disclosed |
| US-20260126721-A1 | EXPANDABLE NEGATIVE PHOTORESIST WITH SUSPENSION MATERIAL AND METHOD FOR REDUCING HORN SHAPES IN SPACER OXIDE USING EXPANDABLE NEGATIVE PHOTORESIST | NANYA TECHNOLOGY CORP (TW) | 2026-05-07 | — | — | US | disclosed |
| US-11367617-B2 | Graded hardmask interlayer for enhanced extreme ultraviolet performance | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2022-06-21 | — | — | US | disclosed |
| JP-2002244298-A | POLYMER BUILT-UP FILM, RESIST COMPRISING POLYMER BUILT-UP FILM, COMPOSITE POLYMER BUILT-UP FILM, RESIST COMPRISING COMPOSITE POLYMER BUILT-UP FILM AND METHOD FOR PRODUCING COMPOSITE POLYMER BUILT-UP FILM | CHISSO CORP | 2002-08-30 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260126722-A1 | EXPANDABLE NEGATIVE PHOTORESIST WITH SUSPENSION MATERIAL AND METHOD FOR REDUCING HORN SHAPES IN SPACER OXIDE USING EXPANDABLE NEGATIVE PHOTORESIST | PSMD1, PSMD13, PSMD7 | AKR1C3 4408/4885AKR1C1 3847/4885MEN1 4414/4885 |
| US-20260126721-A1 | EXPANDABLE NEGATIVE PHOTORESIST WITH SUSPENSION MATERIAL AND METHOD FOR REDUCING HORN SHAPES IN SPACER OXIDE USING EXPANDABLE NEGATIVE PHOTORESIST | GRIN2D, DGKZ, DGKK | AKR1C3 4403/4885AKR1C1 4055/4885MEN1 4161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.